|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yes 2 Success
|
1R25CA233431-01
|
$485,999
|
|
KITTLES, RICK
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
5F31CA213901-02
|
$44,524
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Washington University Human Tumor Atlas Research Center
|
1U2CCA233303-01
|
$1,752,191
|
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
7R00CA207848-04
|
$165,808
|
|
WARREN ANDERSEN, SHANEDA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
4R00CA207848-03
|
$19,074
|
|
WARREN ANDERSEN, SHANEDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
|
2R42CA206744-02A1
|
$665,919
|
|
MCCABE, AARON
|
MINNETRONIX, INC.
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using Microfluidic Single Cell Culture to Characterize Cancer Cell Asymmetric Division
|
7R01CA203810-02
|
$412,307
|
|
BUCKANOVICH, RONALD
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
|
Using functional genomics to inform gene environment interactions for colorectal cancer
|
3R01CA201407-03S1
|
$23,154
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S2
|
$35,000
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S3
|
$124,862
|
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Texas PDX Development and Trial Center
|
3U54CA224065-01S1
|
$175,000
|
|
ROTH, JACK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Rochester Center for AIDS Research
|
3P30AI078498-10S1
|
$98,999
|
|
DEWHURST, STEPHEN
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S1
|
$113,625
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S2
|
$60,000
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S3
|
$250,001
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S1
|
$101,000
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S2
|
$241,905
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S1
|
$39,685
|
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-30S2
|
$243,547
|
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health Disparities
|
1U54CA233306-01
|
$6,160,778
|
|
PAN, CHONG-XIAN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
University of California Global Health Institute Program for Fellows and Scholars
|
3D43TW009343-07S1
|
$123,840
|
|
COHEN, CRAIG
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer Biology
|
4K00CA212454-03
|
$71,550
|
|
RILEY, NICHOLAS
|
STANFORD UNIVERSITY
|
|
Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition
|
1R01CA226864-01A1
|
$607,184
|
|
SCALTRITI, MAURIZIO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding Treatment Tolerability in Older Patients with Cancer
|
1U01CA233167-01
|
$649,295
|
|
MOHILE, SUPRIYA
|
UNIVERSITY OF ROCHESTER
|
|
Understanding the AGL metastasis suppressor for therapeutic gain
|
3R01CA143971-08S1
|
$149,644
|
|
THEODORESCU, DAN
|
CEDARS-SINAI MEDICAL CENTER
|
|
Understanding metabolic vulnerabilities in cancer and the impact the tumor microenvironment has on cancer progression.
|
1F99CA234942-01
|
$36,295
|
|
RUSSELL, SHONAGH
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Understanding metabolic heterogeneity in pancreatic cancer
|
1K99CA234221-01
|
$118,607
|
|
LAU, ALLISON
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding how patient-derived resistance mutations affect the process of imatinib binding to Abl kinase
|
1F30CA225172-01A1
|
$32,574
|
|
LYCZEK, AGATHA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Understanding how patient-derived resistance mutations affect the process of imatinib binding to Abl kinase
|
1F30CA225172-01A1
|
$32,574
|
$32,574
|
LYCZEK, AGATHA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Understanding and Addressing Cancer Health Disparities in Louisiana
|
1P20CA233374-01
|
$976,081
|
|
OCHOA, AUGUSTO
|
LSU HEALTH SCIENCES CENTER
|
|
Uncovering Genotype Specific Vulnerabilities in KRAS Mutant Lung Cancer?
|
1R01CA227649-01A1
|
$387,731
|
|
PAPAGIANNAKOPOULOS, THALES
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
UCLA Center for AIDS Research (CFAR)
|
3P30AI028697-28S1
|
$158,925
|
|
ZACK, JEROME
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UChicago Interdisciplinary Cancer Health Disparities SPORE
|
1P20CA233307-01
|
$1,075,670
|
|
OLOPADE, OLUFUNMILAYO
|
UNIVERSITY OF CHICAGO
|
|
Tumor cell-intrinsic STING signaling and IFN-Beta gene regulation in cancer
|
1F30CA232379-01
|
$49,524
|
|
FLOOD, BLAKE
|
UNIVERSITY OF CHICAGO
|
|
Tubulin microtentacles in detached mammary epithelial cells
|
3R01CA124704-09S1
|
$154,500
|
|
MARTIN, STUART
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)
|
1K43TW010721-01A1
|
$74,124
|
|
NTEKIM, ATARA
|
UNIVERSITY OF IBADAN COLLEGE OF MEDICINE
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $22,159,861
|